RCUS: SEC Form 424B5 filed by Arcus Biosciences Inc.
Stocks in this Quantisnow insightHealth Care
Full content unavailable. See the original source below.
Historical context for RCUS
Across the 29 sessions after earlier RCUS headlines, the stock closed higher 14 times and lower 15 times, with a median move of 2.8% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | RCUS | SPY |
|---|---|---|---|
| Oct 22, 2026 | Arcus Biosciences Announces Commencement of Public Offering of Common Stock | +1.4% | -1.2% |
| Oct 16, 2026 | William Blair initiated coverage on Arcus Biosciences | -3.1% | -1.1% |
| Oct 14, 2026 | Analyst initiated coverage on Arcus Biosciences with a new price target | +0.1% | -1.1% |
| Oct 12, 2026 | Arcus Biosciences Announces New Employment Inducement Grants | -0.3% | -0.1% |
| Sep 25, 2026 | Arcus Biosciences Announces New Employment Inducement Grants | -0.4% | +0.5% |
| Sep 16, 2026 | TD Cowen initiated coverage on Arcus Biosciences | +1.4% | -0.4% |
Quantisnow market dataNYSE
RCUS
Arcus Biosciences Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2018
Get push alerts for RCUS
Full RCUS profile on Quantisnow Follow RCUS and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time